Cyclacel Pharmaceuticals Inc (CYCC)
1.80
-0.05
(-2.70%)
USD |
NASDAQ |
Apr 19, 16:00
1.80
0.00 (0.00%)
After-Hours: 20:00
Cyclacel Pharmaceuticals Net Income (TTM): -22.56M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -22.56M |
| September 30, 2023 | -24.70M |
| June 30, 2023 | -23.77M |
| March 31, 2023 | -22.89M |
| December 31, 2022 | -21.20M |
| September 30, 2022 | -18.64M |
| June 30, 2022 | -18.53M |
| March 31, 2022 | -19.09M |
| December 31, 2021 | -18.46M |
| September 30, 2021 | -16.40M |
| June 30, 2021 | -13.66M |
| March 31, 2021 | -10.70M |
| December 31, 2020 | -8.446M |
| September 30, 2020 | -7.947M |
| June 30, 2020 | -7.592M |
| March 31, 2020 | -7.209M |
| December 31, 2019 | -7.831M |
| September 30, 2019 | -7.544M |
| June 30, 2019 | -7.711M |
| March 31, 2019 | -7.78M |
| December 31, 2018 | -7.287M |
| September 30, 2018 | -7.14M |
| June 30, 2018 | -6.929M |
| March 31, 2018 | -7.264M |
| December 31, 2017 | -7.47M |
| Date | Value |
|---|---|
| September 30, 2017 | -8.438M |
| June 30, 2017 | -9.527M |
| March 31, 2017 | -10.30M |
| December 31, 2016 | -11.79M |
| September 30, 2016 | -12.33M |
| June 30, 2016 | -12.09M |
| March 31, 2016 | -12.47M |
| December 31, 2015 | -14.34M |
| September 30, 2015 | -15.77M |
| June 30, 2015 | -17.96M |
| March 31, 2015 | -19.43M |
| December 31, 2014 | -19.39M |
| September 30, 2014 | -18.15M |
| June 30, 2014 | -18.24M |
| March 31, 2014 | -11.94M |
| December 31, 2013 | -10.15M |
| September 30, 2013 | -11.36M |
| June 30, 2013 | -8.244M |
| March 31, 2013 | -13.31M |
| December 31, 2012 | -13.19M |
| September 30, 2012 | -12.08M |
| June 30, 2012 | -13.64M |
| March 31, 2012 | -13.61M |
| December 31, 2011 | -15.24M |
| September 30, 2011 | -14.76M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-24.70M
Minimum
Sep 2023
-7.209M
Maximum
Mar 2020
-14.99M
Average
-16.40M
Median
Sep 2021
Net Income (TTM) Benchmarks
| Corvus Pharmaceuticals Inc | -27.03M |
| Oragenics Inc | -20.66M |
| Relmada Therapeutics Inc | -98.79M |
| Alpine Immune Sciences Inc | -32.18M |
| MAIA Biotechnology Inc | -19.77M |